What Are M30 Pills? Real vs. Counterfeit Explained

An authentic M30 pill is a 30-milligram immediate-release oxycodone tablet manufactured by Mallinckrodt Pharmaceuticals, identifiable by a small, round, blue tablet stamped with an “M” inside a square on one side and “30” on the other. It is a legitimate prescription painkiller used for moderate-to-severe pain. The problem is that this particular pill has become one of the most counterfeited pharmaceuticals in the United States, with illicit versions now far outnumbering genuine ones in many street markets. These counterfeits look nearly identical to the real thing but typically contain illicitly manufactured fentanyl or other synthetic opioids instead of oxycodone, making them unpredictably lethal.

What the Genuine M30 Actually Is

Oxycodone, the active ingredient in a real M30, is a semi-synthetic opioid that works by binding to opioid receptors in the brain and spinal cord, blocking pain signals and producing a sense of relief or euphoria. Its painkilling strength is roughly comparable to morphine, though the exact ratio varies by the type of pain being treated.¹ At 30 milligrams, the M30 is one of the higher-dose immediate-release oxycodone tablets available, typically reserved for patients who already have some opioid tolerance. It is a Schedule II controlled substance, meaning it has accepted medical uses but carries a high potential for misuse.

Because a 30-milligram dose is strong enough to produce significant euphoria and is widely recognized by name and appearance, the M30 became one of the most sought-after pills on the illicit market long before counterfeits appeared. That demand, combined with its distinctive and easy-to-replicate look, made it a prime target for counterfeiters once illicit fentanyl manufacturing scaled up.

How Counterfeits Took Over the Market

The shift happened fast. A forensic surveillance study tracking pill submissions in Washington, D.C. found that by 2021, nearly two thirds of all pill exhibits submitted to the lab were counterfeit. The majority carried the familiar “30” and “M” imprint with blue coloring, mimicking the genuine oxycodone tablet. Fentanyl was the most commonly detected substance in those counterfeits, showing up in about three quarters of them, though other opioids and even a novel benzodiazepine turned up as well.²

This was not a local anomaly. National seizure data showed that fentanyl-containing pill seizures climbed nearly tenfold between early 2018 and late 2021, and the share of fentanyl seized in pill form more than doubled during that period.³ The counterfeit pill has become a primary delivery vehicle for illicit synthetic opioids, not a fringe phenomenon.

What makes this especially dangerous is the population it reaches. Counterfeit pills look like real medication, and many people who buy them believe they are getting pharmaceutical-grade oxycodone. People who would never knowingly use powder fentanyl or inject heroin end up consuming it without realizing it. Researchers have noted that this dynamic has widened the scope of who is vulnerable to synthetic opioid overdose, pulling in groups like adolescents experimenting with pills and tourists purchasing medications abroad.⁴

What Is Actually Inside a Counterfeit M30

The most common active ingredient in fake M30s is illicitly manufactured fentanyl, but what else ends up in the pill varies wildly. A CDC report on suspected counterfeit M30 exposures found that among patients who came to the hospital, over 90% tested positive for at least one substance beyond fentanyl. The most common co-detected substance was amphetamine or methamphetamine, found in about two thirds of cases, followed by benzodiazepines and cocaine.⁵ Whether those additional substances were in the pills themselves or were consumed separately by the patients is not always clear, but polysubstance exposure is the norm rather than the exception in these cases.

Fentanyl is not even the only synthetic opioid showing up. In France, authorities recently flagged counterfeit oxycodone tablets that contained no oxycodone at all, instead holding metonitazene and protonitazene, members of the nitazene class of synthetic opioids that can be even more potent than fentanyl.⁶ This is not limited to Europe; the broader concern is that counterfeit pill production is agnostic about which synthetic opioid goes inside, and the recipe can change from batch to batch or region to region.

Another adulterant that has become disturbingly common is xylazine, a veterinary sedative sometimes called “tranq.” Xylazine extends and deepens sedation but is not an opioid, which means the standard overdose reversal drug naloxone does not counteract it. Its presence in the fentanyl supply adds a layer of medical complication that emergency responders and people who use drugs are still learning to manage.⁷

The Chocolate Chip Cookie Problem

Even within a single batch of counterfeit pills, the amount of fentanyl in each pill is inconsistent. Illicit manufacturers are not working in quality-controlled pharmaceutical facilities. The fentanyl is mixed into filler powder and pressed, and the distribution of the active ingredient is uneven. One widely used analogy in harm reduction circles is the “chocolate chip cookie effect”: just as chocolate chips are not uniformly spread through cookie dough, fentanyl can be clumped in one part of a pill. One portion of a single pill may contain a far higher concentration than another portion of the same pill.⁸

This makes common harm-reduction advice like “start with half a pill” less reliable than it sounds. Someone might take half and get very little fentanyl, then take the other half and receive a dose several times larger. The inconsistency also means that a person who has safely used pills from a particular source in the past has no guarantee that the next pill is comparably dosed. Every individual pill is essentially an unknown quantity.

Why Fentanyl Is So Much More Dangerous Than Oxycodone

Understanding why swapping oxycodone for fentanyl is so deadly requires knowing a few things about how fentanyl differs from other opioids. Fentanyl is estimated to be roughly 50 to 100 times more potent than morphine by weight, meaning a dose measured in micrograms rather than milligrams can be lethal. But potency alone does not fully explain the danger. Fentanyl also depresses breathing faster than other opioids at equivalent painkilling doses, leaving a much smaller window between taking the drug and losing the ability to breathe.⁹

There is also a phenomenon largely unknown outside of anesthesiology called wooden chest syndrome. At doses only slightly above those that cause sedation, fentanyl and its analogs can trigger profound rigidity in the diaphragm, chest wall, and upper airway. The person’s muscles essentially lock up, making it physically impossible to breathe or to be ventilated with a simple bag-valve mask. Without expert airway management, wooden chest syndrome is almost always fatal.¹⁰ Heroin and morphine can cause mild abdominal muscle rigidity at very high doses, but nothing close to the rapid and total respiratory failure that fentanyl can produce.

A person who is accustomed to 30 milligrams of oxycodone has built tolerance to oxycodone’s effects on breathing. That tolerance does not transfer fully to fentanyl. Cross-tolerance between different opioids is incomplete, meaning someone who can handle a large dose of one opioid may still overdose on a pharmacologically equivalent dose of another, especially one that acts as quickly and broadly as fentanyl.⁹

Can You Tell a Fake M30 From a Real One by Looking at It?

Not reliably. The whole point of counterfeit M30s is that they are designed to pass as real. Illicit manufacturers use commercial-grade pill presses with dies specifically machined to replicate the legitimate M30 imprint, size, shape, and color.¹¹ Some counterfeits have subtle flaws, like slightly uneven edges, inconsistent coloring, or a chalky texture compared to the smooth coating on a genuine tablet. But the quality of counterfeits has improved over time, and none of these visual cues are dependable enough to bet your life on. The only way to confirm whether a pill contains what it claims to is chemical testing.

Drug enforcement agencies and harm reduction organizations have published side-by-side comparison photos, and in many cases even trained pharmacists have difficulty distinguishing real from fake at a glance. If a pill was not dispensed to you directly from a licensed pharmacy with your name on the label, there is no way to be certain it is genuine based on appearance alone.

Testing Options That Actually Exist

Fentanyl test strips are the most accessible tool for checking whether a pill contains fentanyl. Originally developed for urine drug testing, they have been repurposed as a point-of-use harm reduction tool. A person dissolves a small amount of the drug in water and dips the strip in. Research has found that these strips have roughly 96 to 98 percent sensitivity for fentanyl, meaning they catch the vast majority of fentanyl-positive samples, and about 89 percent specificity, meaning false positives are relatively uncommon.¹²

There are important limitations. The strips detect fentanyl itself and some of its analogs, like acetyl fentanyl and furanylfentanyl, but not all. Carfentanil, an extraordinarily potent analog, does not reliably trigger a positive result.¹³ The strips also will not detect nitazenes or xylazine, so a negative result does not mean a pill is safe. There is also lot-to-lot variability in strip performance, and certain substances like methamphetamine, MDMA, and diphenhydramine can cause false positives, though diluting the sample helps reduce that problem.¹⁴

More comprehensive testing exists through drug checking services, which use laboratory-grade instruments like gas chromatography-mass spectrometry to identify everything present in a sample. These services are common in parts of Europe and have expanded in North America, though access remains limited in most U.S. communities.¹⁵ Where available, they provide a far more detailed picture of what is in a sample than any strip test can.

What Happens When Someone Overdoses on a Fake M30

The clinical picture from hospital data is grim. A CDC registry study of 352 suspected counterfeit M30-related cases at a single hospital system between 2017 and 2022 found that about 81 percent of people who arrived after exposure were hospitalized, and nearly 70 percent of those admissions went to an intensive care unit. Patients aged 15 to 34 accounted for roughly two thirds of all exposures.⁵ These are not long-term injection drug users, by and large. The age profile reflects the population of pill consumers who thought they were getting oxycodone.

Naloxone (sold under brand names like Narcan) remains the frontline overdose reversal tool, and it does work against fentanyl’s opioid effects. But fentanyl creates complications that naloxone alone may not fully address. Because fentanyl’s sedative effects can outlast naloxone’s duration of action, a person who initially responds to naloxone can slip back into respiratory depression once the naloxone wears off.¹⁶ Increasingly, first responders and harm reduction workers report that fentanyl-related overdoses require multiple doses of naloxone compared to older opioids.¹⁷ When xylazine is also present, the sedation it causes will persist even after naloxone restores breathing, which can confuse bystanders into thinking the naloxone failed. Calling emergency services is essential even if the person initially appears to respond.

How Counterfeits Reach Buyers

The supply chain for counterfeit M30s starts with bulk fentanyl (or fentanyl precursors) produced largely in illicit labs, combined with commercially available pill presses. The presses themselves are legal manufacturing equipment with legitimate industrial uses, and regulation in the United States has been weak. Federal law limits who can possess pill presses, but penalties for unregistered possession have been relatively light, and state-level laws are generally absent or toothless. China, identified as the primary source of illicitly distributed pill presses, has not enacted laws regulating their sale.¹¹

At the retail level, social media has become a significant marketplace. Sellers use platforms like Snapchat, Instagram, Telegram, and others to advertise counterfeit pills and arrange transactions. They use coded language and evolving slang to evade platform moderation and law enforcement, and the anonymity of these platforms makes enforcement difficult.¹⁸ For young buyers especially, this has collapsed the traditional barriers to accessing drugs. There is no need to know a dealer in person or visit a particular neighborhood. A teenager with a phone and a cash app can arrange delivery with a few messages.

The Withdrawal Side of the Equation

The CDC registry data revealed something that does not get as much attention as acute overdose: of the 352 counterfeit M30-related cases identified, about 59 percent were acute withdrawals, not exposures. In other words, more people presented to the hospital in fentanyl withdrawal than in active overdose.⁵ Fentanyl withdrawal comes on faster and more intensely than withdrawal from longer-acting opioids. People who began using counterfeit M30s thinking they were oxycodone often develop fentanyl dependence without realizing it, and the withdrawal can be severe enough to drive continued use even when the person knows the pills are fake.

When xylazine is involved, the withdrawal picture gets even more complicated. Xylazine withdrawal produces its own set of symptoms that standard opioid withdrawal medications do not address.⁷ Treatment providers are still working out how to manage a syndrome that involves two or more pharmacologically distinct substances acting on different receptor systems. Standard protocols designed around heroin or prescription opioid withdrawal often fall short.

A Problem That Keeps Evolving

The counterfeit M30 crisis is not static. The pills have already moved from being primarily a fentanyl problem to a polysubstance problem, with nitazenes, xylazine, methamphetamine, and benzodiazepines all showing up in different combinations depending on geography and supply chain dynamics. The French alert about nitazene-containing counterfeits is particularly worrying because some nitazenes are believed to be more potent than fentanyl, which would mean even smaller dosing errors become lethal.⁶ The counterfeit pill form itself is also spreading internationally, raising concerns about overdose crises beyond North America in regions where synthetic opioid use has historically been lower.⁴

From a harm reduction standpoint, the most practical takeaway is straightforward: any M30 pill that was not dispensed by a pharmacy for a specific patient should be treated as potentially lethal. Fentanyl test strips are better than nothing but are not comprehensive. Naloxone should be on hand and bystanders should be prepared to administer multiple doses and call 911 regardless of whether the person appears to respond. The gap between what a counterfeit M30 looks like and what it actually contains is one of the most dangerous deceptions in the current drug supply.